Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97 | 38 | 121 | N/A | N/A |
| Receivables | 68 | 66 | 137 | N/A | N/A |
| TOTAL | $165 | $104 | $258 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 821 | 866 | 739 | N/A | N/A |
| Other Non-Current Assets | 137 | 114 | 84 | 0 | 0 |
| TOTAL | $958 | $980 | $823 | $N/A | $N/A |
| Total Assets | $1,123 | $1,084 | $1,083 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 436 | 1,385 | 1,341 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,143 | 2,043 | 1,887 | 0 | 0 |
| TOTAL | $2,579 | $3,428 | $3,228 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 200 | N/A | N/A |
| Other Non-Current Liabilities | 137 | 100 | 83 | 0 | 0 |
| TOTAL | $137 | $100 | $283 | $N/A | $N/A |
| Total Liabilities | $2,716 | $3,528 | $3,511 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 222 | 210 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | 2 | N/A | N/A |
| Retained earnings | -34,606 | -33,750 | -32,488 | N/A | N/A |
| Other shareholders' equity | 491 | 730 | 0 | 0 | 0 |
| TOTAL | $-1,593 | $-2,444 | $-2,428 | $N/A | $N/A |
| Total Liabilities And Equity | $1,123 | $1,084 | $1,083 | $0 | $0 |